SEARCH

SEARCH BY CITATION

References

  • 1
    Stange J, Mitzner S, Ramlow W, Gliesche T, Hickstein H, Schmidt R. A new procedure for the removal of protein bound drugs and toxins. ASAIO J 1993; 39:M621M625.
  • 2
    Stange J, Ramlow W, Mitzner S, Schmidt R, Klinkmann H. Dialysis against a recycled albumin solution enables the removal of albumin bound toxins. Artif Organs 1993; 17:809813.
  • 3
    Scott NL, Sri Prakash M. Hepatocyte liver-assist system—A clinical update. Mayo Clin Proc 1998; 73:765771.
  • 4
    Jaregui HO. Cellular component of bioartificial liver support systems. Artif Organs 1999; 23:889893.
  • 5
    Stange J, Mitzner S. A carrier-mediated transport of toxins in a hybrid membrane. Safety barrier between a patient's blood and a bioartificial liver. Int J Artif Organs 1996; 19:677691.
  • 6
    Mitzner SR, Stange J, Klammt S, Risler T, Erley CM, Bader BD, et al. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: Results of a prospective, randomized, controlled clinical trial. Liver Transpl 2000; 6:277286.
  • 7
    Stange J, Mitzner SR, Risler T, Erley CM, Lauchart W, Goehl H, et al. Molecular adsorbent recycling system (MARS): Clinical results of a new membrane-based blood purification system for bioartificial liver support. Artif Organs 1999; 23:319330.
  • 8
    Mitzner SR, Stange J, Klammt S, Peszynski P, Schmidt R, Noldge-Schomburg G. Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure. J Am Soc Nephrol 2001; 12(suppl 17):S75S82.
  • 9
    Stange J, Mitzner SR, Klammt S, Freytag J, Peszynski P, Look J, et al. Liver support by extracorporeal blood purification: A clinical observation. Liver Transpl 2000; 6:603613.
  • 10
    Mitzner SR, Stange J, Klammt S, Peszynski P, Schmidt R. Albumin dialysis using the molecular adsorbent recirculating system. Curr Opin Nephrol Hypertens 2001; 10:777783.
  • 11
    Sorkine P, Ben Abraham R, Szold O, Biderman P, Kidron A, Merchav H, et al. Role of molecular adsorbent recycling system (MARS) in the treatment of patients with acute exacerbation of chronic liver failure. Crit Care Med 2001; 29:13321336.
  • 12
    Schmidt LE, Svedensen LB, Sorensen VR, Hansen BA, Larsen FS. Cerebral blood flow velocity increases during a single treatment with molecular adsorbents recirculating system in patients with acute-on-chronic liver failure. Liver Transpl 2001; 7:709712.
  • 13
    Schmidt LE, Søorensen VR, Svedensen LB, Hansen BA, Larsen FS. Hemodynamic changes during a single treatment with the molecular adsorbents recirculating system in patients with acute-on-chronic liver failure. Liver Transpl 2001; 7:10341039.
  • 14
    Lebovics E, Seif F, Kim D, Elhosseiny A, Dworkin BM, Casellas A, et al. Pruritus in chronic hepatitis C: Association with high serum bile acid, advanced pathology, and bile duct abnormalities. Dig Dis Sci 1997; 42:10941099.
  • 15
    Chia SC, Berbasa NV, Kleiner DE, Goodman Z, Hoofnagle JH, Di Bisceglie AM. Pruritus as a presenting symptom of chronic hepatitis C. Dig Dis Sci 1998; 43:21772183.
  • 16
    Division of Gastroenterology, Vanderbilt University School of Medicine, Nashville TN. Pruritus of chronic cholestasis. Q J Med 1995; 88:603607.
  • 17
    Ng VL, Ryckman FC, Porta G, Miura IK, De Carvalho E, Servidoni M, et al. Long-term outcome after partial external biliary diversion for intractable pruritus in patients with intrahepatic cholestasis. J Pediatr Gastroenterol Nutr 2000; 30:152156.
  • 18
    Jones EA, Bergasa NV. The pruritus of cholestasis and the opioid system. JAMA 1992; 268:33593362.
  • 19
    Bergasa NV, Thomas DA, Vergalla J, Turner ML, Jones EA. Plasma from patients with the pruritus of cholestasis induces opioid receptor-mediated scratching in monkeys. J Life Sci 1993; 53:12531257.
  • 20
    Marchesini G, Bianchi G, Amodio P, Salerno F, Merli M, Panella C, et al. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology 2001; 120:170178.
  • 21
    Younossi ZM, Kiwi ML, Bopari N, Price LL, Guyatt G. Cholestatic liver disease and health-related quality of life. Am J Gastroenterol 2000; 95:487502.
    Direct Link:
  • 22
    Munoz S. Transplantation of the liver. New York: Elsevier, 1988.
  • 23
    Huster D, Schubert C, Achenbach H, Caca K, Mössner L, Berr F. Successful clinical application of extracorporeal albumin dialysis in a patient with benign recurrent intrahepatic cholestasis (BRIC). Z Gastroenterol 2001; 39:1314.
  • 24
    Avilés J, Marcía M, Morales S, Pérez F, Moreno A, Navarro J, et al. Eficacia de la diálisis con albúmina en el tratamiento de los pacientes con insuficiencia hepática avanzada: primera experiencia en Espana con el sistema MARS. Nefrologia 2001; 26:376385.
  • 25
    Lauterburg BH, Pineda AA, Bergstaler EA, Taswell HF, Dickson HF, Carlson GL. Treatment of pruritus of cholestasis by plasma perfusion through USP-charcoal-coated glass beads. Lancet 1980; 2:5355.
  • 26
    Bernhard JD, Jorizzo JL, Callen JP: Pruritus. In: CallenJL, JorizzoKE, GreerNS, PenneysWW, PietteJJ, ZoneJP (eds). Dermatological signs of internal disease (ed 2). Philadelphia: Saunders, 1995: 7882.
  • 27
    McCoromack HM, de L'Horne DJ, Sheather S. Clinical applications of visual analogue scales: A critical review. Psychol Med 1988; 18:10071019.
  • 28
    Bergasa NV, Alling D, Talbot T, Jones EA. Assessment of the pruritus of cholestasis: An appraisal of the visual analogue scale [abstract]. Hepatology 1990; 12:887A.
  • 29
    Repubblica Italiana. Gazzetta Ufficiale della Regione Siciliana 2002; 30:32.
  • 30
    Pirenne J, Koshiba T. Present status and future prospect in liver transplantation. Int Surg 1999; 84:297304.
  • 31
    Hirose R, Vincenti F. Review of transplantation—1999. Clin Transpl 1999; 295315.